in this issue
Regions :: South America
Abbott to acquire Latin American generic drugs producer CFR for $3 billion
11:59 AM MDT | May 19, 2014 | Natasha Alperowicz
Abbott Laboratories said on Friday that it has signed a definitive agreement to acquire Latin American pharmaceutical company CFR Pharmaceuticals (Santiago), more than doubling the former's Latin American branded generics pharmaceutical presence and further expanding its presence in fast-growing markets. Abbott, under the terms of the agreement, will acquire the holding company that indirectly owns approximately 73% of CFR and will conduct a public cash tender offer for all of the outstanding CFR shares. The total purchase price, assuming all publicly held shares...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee